6th Annual Gene Therapy for Rare Disorders Europe

Kongressthemen
As more and more companies gear up for clinical activity and near approval decisions, the need to have an in-depth understanding of the regulatory frameworks and how these feed into clinical development and manufacturing processes is as vital as ever.

Wissenschaftliche Fach-Gesellschaft
Hanson Wade

Anmerkungen
Speakers: Eva Andres-Mateos, Senior Director of Translational Research, Atsena Therapeutics, Inês Alves, Patient Expert and Member of the Committee for Orphan Medicinal Products, EMA, Stuart Beattie, Gene Therapy Global Regulatory CMC, Biogen

https://go.evvnt.com/1234024-2?pid=4832

Frau Emily Birt